|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.78 CNY | -1.35% |
|
+5.78% | -26.71% |
| Apr. 26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
| Mar. 27 | Biocytogen Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 716.91 million compared to CNY 533.88 million a year ago. Net loss was CNY 382.95 million compared to CNY 601.95 million a year ago.
Basic loss per share from continuing operations was CNY 0.96 compared to CNY 1.58 a year ago. Diluted loss per share from continuing operations was CNY 0.96 compared to CNY 1.58 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.71% | 449M | |
| +25.69% | 47.9B | |
| +46.90% | 41.42B | |
| -3.46% | 40.7B | |
| -6.20% | 28.92B | |
| +9.17% | 25.55B | |
| -20.42% | 19.27B | |
| +0.17% | 12.15B | |
| +28.07% | 12.14B | |
| -1.24% | 11.99B |
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. 
